Nalena Review
Best for: Women seeking transparent low-entry-price ($149/mo) compounded semaglutide or tirzepatide on a GLP-1-only platform with no membership fees, no hidden costs, money-back guarantee, and free 2-day shipping. Not recommended for patients who require brand-name FDA-approved GLP-1s — Nalena is compounded-only.
Nalena (joinnalena.com) is a women-focused, GLP-1-only compounded telehealth platform that operates as a non-clinical technology platform; clinical services are provided by Beluga Health, P.A., a Florida professional association headquartered at 1321 Upland Dr., Suite 18399, Houston, TX 77043. Beluga Health contracts with U.S.-licensed MD/DO physicians providing telemedicine in 49 states. Compounded semaglutide and compounded tirzepatide are offered starting at $149/mo with medication included in the program cost — no separate membership or visit fees. The platform brands itself with a 'no hidden fees / no membership / cancel anytime / money-back guarantee' positioning. Nalena partners with multiple USA-certified pharmacies (not named publicly) and offers free 2-day shipping.
Medium confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Nalena is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Nalena prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Entry tier (starting) | compounded | $149 |
| Entry tier (starting) | compounded | $149 |
✓ Pros
- •Compounded GLP-1 starting at $149/mo with medication included — competitive with the floor of the compounded market and below most multi-product platforms
- •Transparent fee model: 'No Hidden Fees / No Membership / Cancel Anytime' — verbatim brand positioning
- •Money-back guarantee — uncommon vs typical compounded telehealth no-refund posture
- •Clinical provider entity disclosed verbatim: Beluga Health, P.A. (FL Professional Association), 1321 Upland Dr. Suite 18399, Houston, TX 77043 — full transparency
- •Women-focused brand positioning differentiates from gender-neutral compounded providers
- •Free 2-day shipping
- •Both compounded semaglutide AND compounded tirzepatide offered (not single-drug platform)
✗ Cons
- •Per-dose pricing not published — only the 'Starting at $149' entry-level price is disclosed
- •No LegitScript badge, HIPAA seal, or NABP accreditation displayed on public-facing pages
- •Compounding pharmacy partners NOT named publicly (footer only states 'partnered with multiple USA certified pharmacies')
- •Suite 18399 at 1321 Upland Dr., Houston TX 77043 suggests a virtual-office / mail-handling address rather than a clinical facility
- •Brand-name FDA-approved GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) NOT offered — compounded-only platform
- •Women-focused positioning may exclude or under-serve male patients
- •Texas residents may face state-licensure friction — Beluga Health is incorporated in Florida but its Houston address is in Texas
Ready to start with Nalena?
Starting at $149/month. See current pricing and start your free consultation.
Sources & methodology
Our Nalena review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Nalena
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Nalena?
Starting at $149/month. See current pricing and start your free consultation.